Wang Hui, Shen Shutong, Xuan Qinkao, Wang Xiuzhi, Li Xinli, Kong Xiangqing
Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.
Mini Rev Med Chem. 2015;15(6):452-8. doi: 10.2174/1389557515666150324123635.
MicroRNAs are a class of non-coding RNA molecules that have been reported to play a crucial role in cell signaling via post-transcriptional regulation of gene expression. There is increasing evidence showing that this class of RNA is involved in the pathogenesis of cardiovascular diseases, including atherosclerosis. More recently, it has been demonstrated that microRNAs can function to protect against the development of atherosclerosis. The primary goal of this review is to discuss the discovery, mechanism, and therapeutic use of microRNA molecules as atheroprotective agents.
微小RNA是一类非编码RNA分子,据报道它们通过对基因表达的转录后调控在细胞信号传导中发挥关键作用。越来越多的证据表明,这类RNA参与包括动脉粥样硬化在内的心血管疾病的发病机制。最近,已经证明微小RNA可以起到预防动脉粥样硬化发展的作用。本综述的主要目的是讨论微小RNA分子作为抗动脉粥样硬化剂的发现、作用机制和治疗用途。